We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
AUM
$11.8B
AUM Growth
+$11.7B
Cap. Flow
+$973M
Cap. Flow %
8.28%
Top 10 Hldgs %
24.41%
Holding
296
New
40
Increased
100
Reduced
97
Closed
30

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$166M
2
AMGN icon
Amgen
AMGN
+$123M
3
ADSK icon
Autodesk
ADSK
+$114M
4
UNH icon
UnitedHealth
UNH
+$103M
5
MRK icon
Merck
MRK
+$102M

Sector Composition

Rank Sector Weight
1 Technology 24.57%
2 Financials 22.21%
3 Healthcare 21.91%
4 Communication Services 9.53%
5 Industrials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGR icon
51
Progressive
PGR
$125B
$71.2M 0.61%
1,002,500
-17,500
-2% -$1.13M
SSNC icon
52
SS&C Technologies
SSNC
$18.1B
$70.6M 0.6%
1,242,705
+342,113
+38% +$19M
FLEX icon
53
Flex
FLEX
$42.5B
$70.4M 0.6%
7,125,173
+475,544
+7% +$4.98M
SAVE
54
DELISTED
Spirit Airlines, Inc.
SAVE
$68.6M 0.58%
1,460,904
-318,594
-18% -$14.1M
RNR icon
55
RenaissanceRe
RNR
$13.7B
$68.1M 0.58%
510,000
+60,000
+13% +$7.75M
WWE
56
DELISTED
World Wrestling Entertainment
WWE
$65.1M 0.55%
673,462
BRO icon
57
Brown & Brown
BRO
$23.6B
$64.9M 0.55%
2,194,021
-21,235
-1% -$631K
KEX icon
58
Kirby Corp
KEX
$7.76B
$64.5M 0.55%
784,039
+19,814
+3% +$1.66M
BIO icon
59
Bio-Rad Laboratories Class A
BIO
$8.47B
$62.2M 0.53%
198,789
-26,961
-12% -$8.37M
BAX icon
60
Baxter International
BAX
$12.1B
$61.7M 0.52%
800,000
+379,000
+90% +$28.1M
HUM icon
61
Humana
HUM
$45.8B
$61.5M 0.52%
181,637
-58,799
-24% -$19.1M
NOW icon
62
ServiceNow
NOW
$109B
$59.5M 0.51%
1,520,425
+148,340
+11% +$5.61M
TRV icon
63
Travelers Companies
TRV
$81.4B
$58.4M 0.5%
450,000
+75,000
+20% +$9.68M
EBAY icon
64
eBay
EBAY
$50.3B
$58.2M 0.5%
1,763,282
-23,588
-1% -$817K
SRCL
65
DELISTED
Stericycle Inc
SRCL
$57.1M 0.49%
972,668
+70,431
+8% +$4.5M
HCA icon
66
HCA Healthcare
HCA
$86.4B
$55.8M 0.47%
401,048
-208,952
-34% -$26M
ALXN
67
DELISTED
Alexion Pharmaceuticals
ALXN
$55.7M 0.47%
401,000
+186,000
+87% +$23.3M
SCHW
68
Charles Schwab
SCHW
$181B
$55.6M 0.47%
1,131,996
+28,763
+3% +$1.47M
A icon
69
Agilent Technologies
A
$38.9B
$54.9M 0.47%
+778,000
New +$51.5M
CTSH icon
70
Cognizant
CTSH
$22.3B
$54.6M 0.46%
707,651
+18,964
+3% +$1.48M
PRAH
71
DELISTED
PRA Health Sciences, Inc.
PRAH
$54.5M 0.46%
494,853
-71,289
-13% -$7.42M
RGA icon
72
Reinsurance Group of America
RGA
$15.7B
$54.2M 0.46%
375,000
+47,500
+15% +$6.72M
P
73
Everpure Inc
P
$24.7B
$53.5M 0.46%
2,062,496
+379,451
+23% +$9.43M
AON icon
74
Aon
AON
$78.4B
$53.1M 0.45%
345,000
+20,000
+6% +$2.93M
ACN icon
75
Accenture
ACN
$94.3B
$52.2M 0.44%
306,955
+8,459
+3% +$1.41M

Similar funds

Polar Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Polar Capital held 296 positions worth $11.8B, up 70,685% from $16.6M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $973M of net new capital in Q3 2018, opening 40 new positions and adding to 100 existing holdings. Its largest new stake was Johnson & Johnson: 1,250,000 shares worth $173M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $78.6M trimmed.

  • Polar Capital's largest Q3 2018 buy was Johnson & Johnson: 1,250,000 shares worth $173M.
  • Polar Capital added most to UnitedHealth in Q3 2018, an estimated $103M increase.
  • Polar Capital's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $78.6M.
  • Polar Capital fully exited Amdocs in Q3 2018, selling an estimated $46.6K.
  • Polar Capital's ten largest holdings make up 24% of its $11.8B portfolio in Q3 2018.
  • Polar Capital opened 40 new positions and closed 30 in Q3 2018.
  • Polar Capital's portfolio value rose 70,685% quarter-over-quarter to $11.8B.

Based on Polar Capital's 13F filing for Q3 2018, filed 14 Nov 2018.